GA NCORP

Treatment Sites

Georgia Gynecologic Oncology

We welcome you to Georgia Gynecologic Oncology, the practice of Dr. Matthew Burrell and Dr. Stephen Salmieri.

If you, or a woman you love has detected a serious gynecologic abnormality or cancer, you are looking for compassionate guidance in how to meet that challenge in the most informed way possible. You are seeking excellence in therapies, along with the assurance that your treatment plan will be designed uniquely for you. This is the mission and commitment of Georgia Gynecologic Oncology.

GGO is an integral part of the Northside Cancer Institute, and as such, provides state-of-the-art surgery, chemotherapy, and radiation therapy. It also participates in the Institute's clinical trials. Dr. Burrell and Dr. Salmieri each have distinguished reputations as gynecologic oncologists and robotic surgeons. They and their staff are dedicated to the total well-being of their patients in mind, body and spirit. With respect, kindness and compassion, they encourage them to live joyfully, with hope. Their promise is," We will do this together."

Treatment Sites


Primary Location

980 Johnson Ferry Road
Suite 910
Atlanta, GA 30342
404-303-3750 (p)
404-252-4755 (f)
www.ggo-atl.com/

driving directions

Clinical Trials

A Phase 1 Study of Ipilimumab in Combination with Decitabine in Relapsed or Refractory Myelodysplastic Syndrome / Acute Myeloid Leukemia
Cancer Type: Myelodysplastic Syndromes (MDS)

A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients
Cancer Type: Breast Cancer, Unknown Primary

A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Cancer Type: Unspecified

A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I / II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4 / RTOG-3515)
Cancer Type: Lung Cancer

A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Cancer Type: Ovarian Cancer

A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Cancer Type: Unspecified

Cancer Moonshot Biobank Research Protocol
Cancer Type: Unspecified

Integration of Immunotherapy into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Cancer Type: Unspecified